Imaging myocardial scar in hypertrophic cardiomyopathy: advances in CMR and CT

Matteo Sclafani1,2, Chiara Perrotti2, Luigi Salerno2

  • 1Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Insights

Myocardial scarring in hypertrophic cardiomyopathy (HCM) drives adverse outcomes. Advanced imaging like cardiovascular magnetic resonance (CMR) and cardiac computed tomography (CT) are vital for assessing this scar and guiding patient management.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Myocardial scarring is a key feature of hypertrophic cardiomyopathy (HCM), contributing to adverse events like sudden cardiac death and heart failure.
  • The fibrotic tissue in HCM is complex, involving replacement and interstitial fibrosis, often with myocardial disarray.

Purpose of the Study:

  • To review the role of multimodality cardiovascular imaging in assessing myocardial scar in HCM.
  • To focus on cardiovascular magnetic resonance (CMR) and cardiac computed tomography (CT) for scar characterization and discuss their clinical implications.

Main Methods:

  • Cardiovascular magnetic resonance (CMR) techniques including late gadolinium enhancement, T1/T2 mapping, and diffusion tensor imaging.
  • Cardiac computed tomography (CT) methods such as delayed iodine enhancement and CT-derived extracellular volume mapping.

Main Results:

  • CMR is the established gold standard for non-invasive fibrosis assessment in HCM, offering detailed scar insights.
  • CT is an emerging modality providing valuable scar assessment, especially when CMR is not feasible.

Conclusions:

  • Multimodality imaging, particularly CMR and CT, is crucial for characterizing myocardial scar in HCM.
  • Accurate scar assessment aids in risk stratification and personalized management strategies for HCM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
311
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
280
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
389
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453